11/24/2015 - 3:26pm

The Medicare savings that the American College of Physicans says could be saved by focusing on generics is estimated to total $1.4 billion. 

11/24/2015 - 11:18am

Mylan has introduced its generic of Jazz Pharmaceuticals’ schizophrenia treatment. 

11/24/2015 - 10:47am

Following Monday’s announcement that Pfizer would be merging with Ireland-based company Allergan, some analysts are predicting that Pfizer would split the combined company following the $160 billion deal, Reuters reported. According to the report, the split would likely divide the company’s established products (i.e., generics) unit and its innovative medicines unit, composed of drugs that are still patent-protected. (Reuters)

11/23/2015 - 3:49pm

Greenstone received final approval from the Food and Drug Administration for its generic Zyvox. 

11/23/2015 - 1:30pm

Perrigo is buying a Crohn’s disease treatment from AstraZeneca. 

11/20/2015 - 3:55pm

Specialty medications represent only 1% of all prescriptions but, in 2014, these medications resulted in over 31% of all drug spending.

11/20/2015 - 12:10pm

Alchemia’s shareholders approved the sale of Fondaparinux at the company’s annual general meeting held on Nov. 10.

11/20/2015 - 9:50am

With the U.S. Treasury announcing plans to crack down on tax-inversion deals on Thursday, pharmaceutical giants Pfizer and Allergen have accelerated their merger talks, according to reports. The potential $150 billion deal could see Pfizer redomicile in Ireland. (Reuters)

11/19/2015 - 2:26pm

The drug will be available in 5-, 7.5-, 10-, 12.5, 15-, 20- and 30-mg tablets.